The global carglumic acid market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to accelerate the growth of the market during the forecast period include the rising prevalence of cancer and growing incidences of metabolic disorders such as hepatic encephalopathy, Reye’s syndrome, and cirrhosis. Thus, resulting in excess levels of ammonia in the blood, resultant higher demand for treatment. For instance, according to the report published by the National Library of Medicine in December 2019, N -acetyl glutamate synthase deficiency is estimated to affect 1 in 2 million people globally, which fuels the demand for carglumic acid globally. Moreover, carglumic acid has also shown potential for anti-tumor activity in breast cancer, which is expected to fuel the global carglumic acid market during the forecast period.

Carglumic acid is an orphan drug used to treat hyperammonemia also known as NAGS Syndrome, a rare genetic disorder that occurs due to lack of an enzyme called N-acetyl glutamate synthase (NAGS) in the liver results in elevated levels of ammonia in the blood. Various neurological disorders such as congenital deficiencies of urea cycle enzymes, hepatic encephalopathy, Reye’s syndrome, several other metabolic disorders occur with the increased levels of ammonia demanding the necessity for carglumic acid during the forecast period. The global carglumic acid market is moderately competitive and consists of several major players. In terms of market revenue, few of the prominent players currently dominating the market are applying various strategies such as acquiring the products or other companies to consolidate their market positions across the globe, while others are focusing on generic product approvals. For instance, a rise in API manufacturers such as Suven and Apothecan in India generates revenue by supplying the API to meet the demand for carglumic acid, which is a factor that is boosting the market growth during the forecast period. 

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Recordati S.p.A., Apothecon Pharmaceuticals Pvt. Ltd., and Manus Aktteva Biopharma LLP, among others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Carglumic Acid Market Report by Segment

By Dosage Form

• Orally Disintegrating Tablets

• Dispersible Tablets

• Others

By Distribution Channel

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

Global Carglumic Acid Market by Region